SGLT2 inhibitors and GLP-1 receptor agonists: which is the best anti-frailty drug?

2024-9-1

Effect of frailty on effectiveness and safety of GLP-1 receptor agonists versus SGLT2 inhibitors in people with type 2 diabetes in Taiwan: a retrospective, nationwide, longitudinal study

2024-9-1

Association between surgical admissions, cognition, and neurodegeneration in older people: a population-based study from the UK Biobank

2024-9-1

Reserve and resilience: the cumulative risk of surgery on cognition and neurodegeneration in older individuals

2024-9-1

Effect of an exercise intervention or combined exercise and diet intervention on health-related quality of life-physical functioning after kidney transplantation: the Active Care after Transplantation (ACT) multicentre randomised controlled trial

2024-9-1

Improving health-related quality of life after kidney transplantation using lifestyle interventions

2024-9-1

Life-course financial mobility shapes later-life memory function

2024-8-1

Association between Geriatric 8 frailty and health-related quality of life in older patients with cancer (PROGNOSIS-G8): a Danish single-centre, prospective cohort study

2024-8-1

Correction to Lancet Healthy Longev 2024; 5: 552–562

2024-8-1

Global barriers to hip-fracture care

2024-8-1

Combating dementia: the imperative for population-level interventions

2024-8-1

Effect of antihypertensive deprescribing on hospitalisation and mortality: long-term follow-up of the OPTiMISE randomised controlled trial

2024-8-1

Life course financial mobility and later-life memory function and decline by gender, and race and ethnicity: an intersectional analysis of the US KHANDLE and STAR cohort studies

2024-8-1

The associations of socioeconomic status, social activities, and loneliness with depressive symptoms in adults aged 50 years and older across 24 countries: findings from five prospective cohort studies

2024-8-1

Psychosocial pathways linking differences in socioeconomic status to symptoms of depression

2024-8-1

Associations of social determinants of health with life expectancy and future health risks among individuals with type 2 diabetes: two nationwide cohort studies in the UK and USA

2024-8-1

The effect of frailty on mortality and hospital admission in patients with benign pleural disease in Wales: a cohort study

2024-8-1

More than simply leftovers: a new link between remnant cholesterol and dementia

2024-8-1

The effect of frailty in pleural disease

2024-8-1

Deprescribing for older adults with hypertension at high risk for adverse events: not so fast

2024-7-30

Leadership – can you be too old?

2024-7-30

The economic burden of cancer, coronary heart disease, dementia, and stroke in England in 2018, with projection to 2050: an evaluation of two cohort studies

2024-7-26

Different reasonable methodological choices can lead to vastly different estimates of the economic burden of diseases

2024-7-26

Association of remnant cholesterol with risk of dementia: a nationwide population-based cohort study in South Korea

2024-7-26

Time from injury to hip-fracture surgery in low-income and middle-income regions: a secondary analysis of data from the International Orthopaedic Multicentre Study in Fracture Care (INORMUS)

2024-7-1

Frailty progression in adults aged 40 years and older in rural Burkina Faso: a longitudinal, population-based study

2024-7-1

Association of intrinsic capacity with functional decline and mortality in older adults: a systematic review and meta-analysis of longitudinal studies

2024-7-1

Benefits of population-level interventions for dementia risk factors: an economic modelling study for England

2024-7-1

Ageing with grace and graft

2024-7-1

Obesity and risk of diseases associated with hallmarks of cellular ageing: a multicohort study

2024-7-1

Temporal trends in the prevalence of Parkinson's disease from 1980 to 2023: a systematic review and meta-analysis

2024-6-27

Physical activity knows no age limit

2024-6-27

Intrinsic capacity assessment works—let's move on actions

2024-6-27

Highlights of the 2024 Annual Scientific Meeting of the American Geriatrics Society

2024-6-27

Adapted EXTREME regimen in the first-line treatment of fit, older patients with recurrent or metastatic head and neck squamous cell carcinoma (ELAN-FIT): a multicentre, single-arm, phase 2 trial

2024-6-1

The need to include older patients with head and neck cancer in clinical trials

2024-6-1

Prevention of dementia using mobile phone applications (PRODEMOS): a multinational, randomised, controlled effectiveness–implementation trial

2024-6-1

Value-based motivational strategies combined with technology to encourage a lifestyle that helps to prevent dementia

2024-5-30

Understanding the needs of forcibly displaced people

2024-5-30

The role of dementia in the association between APOE4 and all-cause mortality: pooled analyses of two population-based cohort studies

2024-5-30

The need for a more holistic approach to dementia prevention

2024-5-30

Eldecalcitol for sarcopenia prevention in adults with prediabetes – Authors' reply

2024-5-30

Eldecalcitol for sarcopenia prevention in adults with prediabetes

2024-5-30

Are mobile health applications the answer to dementia risk reduction?

2024-5-30

Long-term effects of APOEε4 on mortality

2024-5-30

Polypharmacy research: in need of a new conceptual framework

2024-5-30

Population attributable fractions of modifiable risk factors for dementia: a systematic review and meta-analysis

2024-5-30

Universal palliative care for healthy longevity

2024-5-1

Where is the perfect triangle in the liver allocation system?

2024-5-1

Age-specific mortality trends in heart failure over 25 years: a retrospective Danish nationwide cohort study

2024-5-1